Bio-Medisinsk Innovasjon AS
This article was originally published in Start Up
Executive SummaryFailing hearts are able to bind more serotonin than normal hearts, which prompted the founders of Bio-Medisinsk Innovasjon to look for heart failure treatments in agents capable of inhibiting serotonin.
You may also be interested in...
Outsourcing is not just for mundane pharma services anymore. Increasingly, drugmakers are contracting for specialized R&D assistance they expect to provide strategic as well as tactical advantages.